LIPID MANAGEMENT IN HIGH-RISK PATIENTS

International Society cooperate to hardening of the arteries (IAS) and Pfizer Pfizer to provide grants developmental and training based on independent initiatives that seek to update and implementation of training courses in the field of lipid management as well as the investment of new developments in fat treatment using antibodies monoclonal and genetics of cardiovascular and its association with disease hypercholesterolemia family. Will be and should be one of the proposals submitted died the following subsections:

1 - programs or educational resources for healthcare professionals

2 - clinical practice tools such as calculators or risk processing algorithms

3 - educational materials, resources or patient advocacy programs.
This RFP issued by the two organizations. IAS is the leading organization to review and evaluate applications. The committee will review, led by the International Accounting Standard, and make decisions on the proposals will receive funding. The grant funding will be provided by Pfizer.

The International Society of atherosclerosis (IAS) is responsible for reviewing and evaluating proposals while Pfizer provides financial support Aisalala $ 2 million to the winning projects.

.Time system

6 October 2015 is to provide the letter of intent and has a summary of the project
December 1 shall be notified of the accepted ideas to provide full proposals,
February 4, 2016 deadline for submission of full proposals
April 13, 2016 announcement of the results and notify the winners and are beyond the signing of the agreement with the winning institution.
May 1, 2016 start implementation of the winning projects and continue for two years.

Progress and delivery system proposals

The access to the site the following:

www.pfizer.com/independentgrants

To inquire from the donor is use the following e-mail:

Jacqueline.Waldrop@pfizer.com



Technical support for further information please contact the Development Unit project management.

T / 0552372518

Mobile